2 Minute Medicine2d
Evidence gap for acute pain outcomes in opioid use disorder
In this systematic review, evidence for the efficacy of acute pain interventions on individuals with opioid use disorder was ...
WebMD1mon
FDA Approves New Label for Opioid Use Disorder Drug
Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...
WebMD1y
Substance Abuse & Addiction Resource Center
FDA Approves New Label for Opioid Use Disorder DrugThe FDA has approved a new treatment plan a long-acting injection called Sublocade, making it easier for people with moderate to severe opioid ...
Medscape7d
Can Safer-Use Strategies in Primary Care Improve Opioid and Stimulant Care?
Safer-use strategies in primary care patients who use stimulants and/or opioids are deemed acceptable by both patients and ...